IP Library › Granted Patent US 12,227,803
Granted Patent B2
US 12,227,803 · App. 17/523,706 · Granted Feb 18, 2025

Methods and compositions for efficient base calling in sequencing reactions

Inventor: Radoje Drmanac (Los Altos Hills, CA)
Assignee: Complete Genomics, Inc.
C12Q1/6874C12Q1/686C12Q1/6869C12Q1/6876C12Q1/68C12Q2565/102C12Q2565/1025
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,227,803
App. No.
17/523,706
Granted
Feb 18, 2025
Kind
B2
Abstract

The present invention is directed to methods and compositions for acquiring nucleotide sequence information of target sequences. In particular, the present invention provides methods and compositions for improving the efficiency of sequencing reactions by using fewer labels to distinguish between nucleotides and by detecting nucleotides at multiple detection positions in a target sequence.

Claims (18)

1. A method for determining nucleotide sequences from a plurality of different nucleic acid templates disposed at different array positions on a surface of a nucleic acid array, wherein each array position of the different array positions comprises a plurality of copies of one nucleic acid template of the plurality of different nucleic acid templates, wherein the method comprises conducting multiple cycles of sequencing-by-synthesis at each of the different array positions,

wherein in each cycle of the multiple cycles of sequencing-by-synthesis, at each array position of the different array positions, a nucleotide selected from A, T, G and C anneals to a complementary nucleotide at a detection position of the plurality of copies of the one nucleic acid template, wherein at least three of the nucleotides selected from A, T, G and C are labeled with a fluorescent label that produces a fluorescent signal or at least three of the nucleotides selected from A, T, G and C are labeled with a luminescent label that produces a luminescent signal,

wherein each cycle of the multiple cycles of sequencing-by-synthesis comprises

(i) at each of a plurality of first array positions of the different array positions, binding a first nucleotide selected from A, T, G and C to a first complementary nucleotide at the detection position of the plurality of copies of the one nucleic acid template disposed at the first array positions, wherein the first nucleotide is complementary to the first complementary nucleotide,

(ii) at each of a plurality of second array positions of the different array positions, binding a second nucleotide selected from A, T, G and C to a second complementary nucleotide at the detection position of the plurality of copies of the one nucleic acid template disposed at the second array positions, wherein the second nucleotide is complementary to the second complementary nucleotide,

(iii) at each of a plurality of third array positions of the different array positions, binding a third nucleotide selected from A, T, G and C to a third complementary nucleotide at the detection position of the plurality of copies of the one nucleic acid template disposed at the third array positions, wherein the third nucleotide is complementary to the third complementary nucleotide,

(iv) at each of a plurality of fourth array positions, binding a fourth nucleotide selected from A, T, G and C to a fourth complementary nucleotide at the detection position of the plurality of copies of the one nucleic acid template disposed at the fourth array positions, wherein the fourth nucleotide is complementary to the fourth complementary nucleotide,

wherein each of the first nucleotide, the second nucleotide, the third nucleotide and the fourth nucleotide is one of A, T, G and C,

wherein none of the first nucleotide, the second nucleotide, the third nucleotide and the fourth nucleotide is the same, wherein the plurality of first array positions, the plurality of second array positions, the plurality of third array positions and the plurality of fourth array positions are non-overlapping subsets of the different array positions on the surface of the nucleic acid array;

wherein the first nucleotide, the second nucleotide, the third nucleotide and the fourth nucleotide are labeled with the same fluorescent label or luminescent label but produce fluorescent or luminescent signals having different intensities, or

wherein three of the first nucleotide, the second nucleotide, the third nucleotide and the fourth nucleotide are labeled with the same fluorescent label or luminescent label but produce fluorescent or luminescent signals having different intensities and one of the first nucleotide, the second nucleotide, the third nucleotide and the four nucleotide has no fluorescent label or luminescent label,

wherein the first nucleotide, the second nucleotide, the third nucleotide and the fourth nucleotide are identified and distinguished from each other based on intensities of their fluorescent or luminescent signals, and

(v) determining whether a complementary nucleotide at a detection position of the plurality of copies of the one nucleic acid template at each of the plurality of first array positions, the plurality of second array positions, the plurality of third array positions and the plurality of fourth array positions is A, T, G or C, by detecting an intensity of fluorescent or luminescent signal at each of the plurality of first array positions, the plurality of second array positions, the plurality of third array positions and the plurality of fourth array positions.

2. The method of claim 1 , wherein the nucleic acid array is a DNA nanoball array.

3. The method of claim 1 , wherein the first nucleotide is A.

4. The method of claim 1 , wherein the first nucleotide is T.

5. The method of claim 1 , wherein the first nucleotide is G.

6. The method of claim 1 , wherein the first nucleotide is C.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2024
From: DRMANAC, RADOJE
To: COMPLETE GENOMICS, INC.
Reel/Frame 068426/0181 →
Continuity (6)
Continuation 15359277 · Nov 22, 2016
Continuation 14094630 · Dec 2, 2013
Continuation 12361507 · Jan 28, 2009
Provisional Application 61024396 · Jan 29, 2008
Provisional Application 61024110 · Jan 28, 2008
Related Publication 20220275442A1 · Sep 1, 2022
References Cited (400)
US 4719179A · Barany · 1988 [cited by applicant]
US 4863879A · Kwok · 1989 [cited by applicant]
US 4883750A · Whiteley et al. · 1989 [cited by applicant]
US 5091302A · Newman et al. · 1992 [cited by applicant]
US 5124246A · Urdea et al. · 1992 [cited by applicant]
US 5143854A · Pirrung et al. · 1992 [cited by applicant]
US 5202231A · Drmanac et al. · 1993 [cited by applicant]
US 5302509A · Cheeseman · 1994 [cited by applicant]
US 5354668A · Auerbach · 1994 [cited by applicant]
US 5403708A · Brennan et al. · 1995 [cited by applicant]
US 5405747A · Jett et al. · 1995 [cited by applicant]
US 5426180A · Kool · 1995 [cited by applicant]
US 5427930A · Birkenmeyer et al. · 1995 [cited by applicant]
US 5436130A · Mathies et al. · 1995 [cited by applicant]
US 5474796A · Brennan · 1995 [cited by applicant]
US 5508169A · Deugau et al. · 1996 [cited by applicant]
US 5525464A · Drmanac et al. · 1996 [cited by applicant]
US 5547839A · Dower et al. · 1996 [cited by applicant]
US 5632957A · Heller et al. · 1997 [cited by applicant]
US 5641658A · Adams et al. · 1997 [cited by applicant]
US 5648245A · Fire et al. · 1997 [cited by applicant]
US 5667971A · Hochberg · 1997 [cited by applicant]
US 5710000A · Sapolsky et al. · 1998 [cited by applicant]
US 5714320A · Kool · 1998 [cited by applicant]
US 5728524A · Sibson · 1998 [cited by applicant]
US 5728528A · Mathies et al. · 1998 [cited by applicant]
US 5744305A · Fodor et al. · 1998 [cited by applicant]
US 5800992A · Fodor et al. · 1998 [cited by applicant]
US 5804386A · Ju · 1998 [cited by applicant]
US 5837832A · Chee et al. · 1998 [cited by applicant]
US 5854033A · Lizardi · 1998 [cited by applicant]
US 5866337A · Schon · 1999 [cited by applicant]
US 5871921A · Landegren et al. · 1999 [cited by applicant]
US 5888737A · DuBridge et al. · 1999 [cited by applicant]
US 5952180A · Ju · 1999 [cited by applicant]
US 5976802A · Ansorge et al. · 1999 [cited by applicant]
US 5994068A · Guilfoyle et al. · 1999 [cited by applicant]
US 6001566A · Canard et al. · 1999 [cited by applicant]
US 6004755A · Wang · 1999 [cited by applicant]
US 6013445A · Albrecht et al. · 2000 [cited by applicant]
US 6045994A · Zabeau et al. · 2000 [cited by applicant]
US 6077668A · Kool · 2000 [cited by applicant]
US 6087095A · Rosenthal et al. · 2000 [cited by applicant]
US 6087101A · Gruelich et al. · 2000 [cited by applicant]
US 6096880A · Kool · 2000 [cited by applicant]
US 6124120A · Lizardi · 2000 [cited by applicant]
US 6136537A · Macevicz · 2000 [cited by applicant]
US 6143495A · Lizardi et al. · 2000 [cited by applicant]
US 6143527A · Pachuk et al. · 2000 [cited by applicant]
US 6210891B1 · Nyren et al. · 2001 [cited by applicant]
US 6210894B1 · Brennan · 2001 [cited by applicant]
US 6218124B1 · Lee · 2001 [cited by applicant]
US 6218152B1 · Auerbach · 2001 [cited by applicant]
US 6221603B1 · Mahtani · 2001 [cited by applicant]
US 6255469B1 · Seeman et al. · 2001 [cited by applicant]
US 6258539B1 · Hunkapiller et al. · 2001 [cited by applicant]
US 6261808B1 · Auerbach · 2001 [cited by applicant]
US 6270961B1 · Drmanac · 2001 [cited by applicant]
US 6274320B1 · Rothberg et al. · 2001 [cited by applicant]
US 6274351B1 · Peponnet · 2001 [cited by applicant]
US 6284497B1 · Sabanayagam et al. · 2001 [cited by applicant]
US 6287824B1 · Lizardi · 2001 [cited by applicant]
US 6291183B1 · Pirrung et al. · 2001 [cited by applicant]
US 6297006B1 · Drmanac et al. · 2001 [cited by applicant]
US 6297016B1 · Egholm et al. · 2001 [cited by applicant]
US 6306597B1 · Macevicz · 2001 [cited by applicant]
US 6309824B1 · Drmanac · 2001 [cited by applicant]
US 6316229B1 · Lizardi et al. · 2001 [cited by applicant]
US 6329150B1 · Lizardi et al. · 2001 [cited by applicant]
US 6344316B1 · Lockhart et al. · 2002 [cited by applicant]
US 6344329B1 · Lizardi · 2002 [cited by applicant]
US 6346413B1 · Fodor et al. · 2002 [cited by applicant]
US 6355432B1 · Fodor et al. · 2002 [cited by applicant]
US 6401267B1 · Drmanac · 2002 [cited by applicant]
US 6403311B1 · Chan · 2002 [cited by applicant]
US 6403320B1 · Read et al. · 2002 [cited by applicant]
US 6413722B1 · Arnold et al. · 2002 [cited by applicant]
US 6432360B1 · Church · 2002 [cited by applicant]
US 6436641B1 · Izmailov · 2002 [cited by applicant]
US 6472156B1 · Wittwer et al. · 2002 [cited by applicant]
US 6491871B1 · Fodor et al. · 2002 [cited by applicant]
US 6500620B2 · Yu et al. · 2002 [cited by applicant]
US 6514768B1 · Guire et al. · 2003 [cited by applicant]
US 6534293B1 · Barany et al. · 2003 [cited by applicant]
US 6558928B1 · Landegren · 2003 [cited by applicant]
US 6573369B2 · Henderson et al. · 2003 [cited by applicant]
US 6576448B2 · Weissman et al. · 2003 [cited by applicant]
US 6589726B1 · Butler et al. · 2003 [cited by applicant]
US 6610481B2 · Koch · 2003 [cited by applicant]
US 6620584B1 · Chee et al. · 2003 [cited by applicant]
US 6632609B2 · Lizardi · 2003 [cited by applicant]
US 6653077B1 · Brenner · 2003 [cited by applicant]
US 6723513B2 · Lexow · 2004 [cited by applicant]
US 6783943B2 · Christian et al. · 2004 [cited by applicant]
US 6787308B2 · Balasubramanian et al. · 2004 [cited by applicant]
US 6812005B2 · Fan et al. · 2004 [cited by applicant]
US 6828100B1 · Ronaghi · 2004 [cited by applicant]
US 6833246B2 · Balasubramanian · 2004 [cited by applicant]
US 6864052B1 · Drmanac et al. · 2005 [cited by applicant]
US 6869764B2 · Williams et al. · 2005 [cited by applicant]
US 6890741B2 · Fan et al. · 2005 [cited by applicant]
US 6911345B2 · Quake et al. · 2005 [cited by applicant]
US 6913884B2 · Stuelpnagel et al. · 2005 [cited by applicant]
US 6977153B2 · Kumar et al. · 2005 [cited by applicant]
US 6998228B2 · Henderson et al. · 2006 [cited by applicant]
US 7011945B2 · Qiao et al. · 2006 [cited by applicant]
US 7033754B2 · Chee et al. · 2006 [cited by applicant]
US 7056661B2 · Korlach et al. · 2006 [cited by applicant]
US 7064197B1 · Rabbani et al. · 2006 [cited by applicant]
US 7226734B2 · Chee et al. · 2007 [cited by applicant]
US 7244559B2 · Rothberg et al. · 2007 [cited by applicant]
US 7264929B2 · Rothberg et al. · 2007 [cited by applicant]
US 7276720B2 · Ulmer · 2007 [cited by applicant]
US 7282337B1 · Harris · 2007 [cited by applicant]
US 7384737B2 · Barnes · 2008 [cited by applicant]
US 7544473B2 · Brenner · 2009 [cited by applicant]
US 7709197B2 · Drmanac · 2010 [cited by applicant]
US 7897344B2 · Dahl et al. · 2011 [cited by applicant]
US 7901891B2 · Drmanac · 2011 [cited by applicant]
US 7906285B2 · Drmanac · 2011 [cited by applicant]
US 7910302B2 · Drmanac et al. · 2011 [cited by applicant]
US 7910304B2 · Drmanac · 2011 [cited by applicant]
US 7910354B2 · Drmanac et al. · 2011 [cited by applicant]
US 7960104B2 · Drmanac et al. · 2011 [cited by applicant]
US 8105771B2 · Drmanac · 2012 [cited by applicant]
US 8133719B2 · Drmanac et al. · 2012 [cited by applicant]
US 8236532B2 · Ronaghi et al. · 2012 [cited by applicant]
US 8278039B2 · Drmanac · 2012 [cited by applicant]
US 8298768B2 · Dramanac et al. · 2012 [cited by applicant]
US 8415099B2 · Drmanac et al. · 2013 [cited by applicant]
US 8440397B2 · Drmanac et al. · 2013 [cited by applicant]
US 8445194B2 · Drmanac et al. · 2013 [cited by applicant]
US 8445196B2 · Drmanac et al. · 2013 [cited by applicant]
US 8445197B2 · Drmanac et al. · 2013 [cited by applicant]
US 8518640B2 · Drmanac et al. · 2013 [cited by applicant]
US 8551702B2 · Drmanac et al. · 2013 [cited by applicant]
US 8617811B2 · Drmanac · 2013 [cited by applicant]
US 9115163B2 · Ju et al. · 2015 [cited by applicant]
US 9222132B2 · Drmanac · 2015 [cited by applicant]
US 9523125B2 · Drmanac · 2016 [cited by applicant]
US 10662473B2 · Drmanac · 2020 [cited by applicant]
US 11098356B2 · Drmanac · 2021 [cited by applicant]
US 11214832B2 · Drmanac · 2022 [cited by applicant]
US 20020004204A1 · O'Keefe · 2002 [cited by applicant]
US 20020039738A1 · Williams et al. · 2002 [cited by applicant]
US 20020055100A1 · Kawashima et al. · 2002 [cited by applicant]
US 20020076716A1 · Sabanayagam et al. · 2002 [cited by applicant]
US 20020164629A1 · Quake et al. · 2002 [cited by applicant]
US 20020192697A1 · Izmailov · 2002 [cited by applicant]
US 20020197621A1 · Drmanac · 2002 [cited by applicant]
US 20030044781A1 · Korlach et al. · 2003 [cited by applicant]
US 20030068629A1 · Rothberg et al. · 2003 [cited by applicant]
US 20030200033A1 · Segal et al. · 2003 [cited by applicant]
US 20040002090A1 · Mayer et al. · 2004 [cited by applicant]
US 20040076998A1 · Lexow · 2004 [cited by applicant]
US 20040229221A1 · Schon · 2004 [cited by applicant]
US 20040248144A1 · Mir · 2004 [cited by applicant]
US 20040248161A1 · Rothberg et al. · 2004 [cited by applicant]
US 20050019776A1 · Callow et al. · 2005 [cited by applicant]
US 20050037356A1 · Gullberg et al. · 2005 [cited by applicant]
US 20050042649A1 · Balasubramanian et al. · 2005 [cited by applicant]
US 20050100893A1 · Gunderson et al. · 2005 [cited by applicant]
US 20050100939A1 · Namsaraev et al. · 2005 [cited by applicant]
US 20050149272A1 · Pe' Er et al. · 2005 [cited by applicant]
US 20050181394A1 · Steemers et al. · 2005 [cited by applicant]
US 20050191656A1 · Drmanac et al. · 2005 [cited by applicant]
US 20050191698A1 · Chee et al. · 2005 [cited by applicant]
US 20050214840A1 · Chen · 2005 [cited by applicant]
US 20050244863A1 · Mir · 2005 [cited by applicant]
US 20060012793A1 · Harris · 2006 [cited by applicant]
US 20060024681A1 · Smith et al. · 2006 [cited by applicant]
US 20060024711A1 · Lapidus et al. · 2006 [cited by applicant]
US 20060063264A1 · Turner et al. · 2006 [cited by applicant]
US 20060211010A1 · Korlach et al. · 2006 [cited by applicant]
US 20060223097A1 · Sapolsky et al. · 2006 [cited by applicant]
US 20070015182A1 · Abarzua · 2007 [cited by applicant]
US 20070031875A1 · Buzby · 2007 [cited by applicant]
US 20070037152A1 · Drmanac · 2007 [cited by applicant]
US 20070037197A1 · Young et al. · 2007 [cited by applicant]
US 20070072208A1 · Drmanac · 2007 [cited by applicant]
US 20070099208A1 · Drmanac et al. · 2007 [cited by applicant]
US 20070219367A1 · Shchepinov et al. · 2007 [cited by applicant]
US 20080234136A1 · Drmanac et al. · 2008 [cited by applicant]
US 20080318796A1 · Drmanac et al. · 2008 [cited by applicant]
US 20090005252A1 · Drmanac et al. · 2009 [cited by applicant]
US 20090005259A1 · Drmanac · 2009 [cited by applicant]
US 20090011416A1 · Drmanac · 2009 [cited by applicant]
US 20090011943A1 · Drmanac et al. · 2009 [cited by applicant]
US 20090036316A1 · Drmanac · 2009 [cited by applicant]
US 20090099041A1 · Church et al. · 2009 [cited by applicant]
US 20090118488A1 · Drmanac et al. · 2009 [cited by applicant]
US 20090137404A1 · Drmanac et al. · 2009 [cited by applicant]
US 20090137414A1 · Drmanac et al. · 2009 [cited by applicant]
US 20090155781A1 · Drmanac et al. · 2009 [cited by applicant]
US 20090263802A1 · Drmanac · 2009 [cited by applicant]
US 20090264299A1 · Drmanac et al. · 2009 [cited by applicant]
US 20090305248A1 · Lander et al. · 2009 [cited by applicant]
US 20100105052A1 · Drmanac et al. · 2010 [cited by applicant]
US 20110071053A1 · Drmanac et al. · 2011 [cited by applicant]
US 20110281738A1 · Drmanac et al. · 2011 [cited by applicant]
US 20120100534A1 · Drmanac et al. · 2012 [cited by applicant]
US 20120141986A1 · Kuhn et al. · 2012 [cited by applicant]
US 20140356865A1 · Drmanac · 2014 [cited by applicant]
US 20140378321A1 · Drmanac · 2014 [cited by applicant]
US 20170292157A1 · Drmanac · 2017 [cited by applicant]
US 20180346980A1 · Drmanac · 2018 [cited by applicant]
US 20200318183A1 · Drmanac · 2020 [cited by applicant]
CN 101570784A · 2009 [cited by applicant]
EP 0805190A2 · 1997 [cited by applicant]
JP 04262799A · 1992 [cited by applicant]
JP 04304900A · 1992 [cited by applicant]
JP 07244046A · 1995 [cited by applicant]
WO 9106678A1 · 1991 [cited by applicant]
WO 9509248A1 · 1995 [cited by applicant]
WO 9844151A1 · 1998 [cited by applicant]
WO 0109384A2 · 2001 [cited by applicant]
WO 0162982A2 · 2001 [cited by applicant]
WO 02074988A2 · 2002 [cited by applicant]
WO 03012119A2 · 2003 [cited by applicant]
WO 2004018493A1 · 2004 [cited by applicant]
WO 2004018497A2 · 2004 [cited by applicant]
WO 2004018497A3 · 2004 [cited by applicant]
WO 2004072294A2 · 2004 [cited by applicant]
WO 2004076683A2 · 2004 [cited by applicant]
WO 2005024010A1 · 2005 [cited by applicant]
WO 2005040425A2 · 2005 [cited by applicant]
WO 2005047523A2 · 2005 [cited by applicant]
WO 2005078130A1 · 2005 [cited by applicant]
WO 2005080605A2 · 2005 [cited by applicant]
WO 2005082098A2 · 2005 [cited by applicant]
WO 2005093094A2 · 2005 [cited by applicant]
WO 2005116262A1 · 2005 [cited by applicant]
WO 2006007207A2 · 2006 [cited by applicant]
WO 2006040549A2 · 2006 [cited by applicant]
WO 2006055521A2 · 2006 [cited by applicant]
WO 2006064199A1 · 2006 [cited by applicant]
WO 2006073504A2 · 2006 [cited by applicant]
WO 2006084132A2 · 2006 [cited by applicant]
WO 2006120433A1 · 2006 [cited by applicant]
WO 2006138257A2 · 2006 [cited by applicant]
WO 2007014397A2 · 2007 [cited by applicant]
WO 2007025124A1 · 2007 [cited by applicant]
WO 2007061425A1 · 2007 [cited by applicant]
WO 2007062160A2 · 2007 [cited by applicant]
WO 2007010251A3 · 2007 [cited by applicant]
WO 2007106509A2 · 2007 [cited by applicant]
WO 2007120208A2 · 2007 [cited by applicant]
WO 2007121489A2 · 2007 [cited by applicant]
WO 2007123744A2 · 2007 [cited by applicant]
WO 2007133831A2 · 2007 [cited by applicant]
WO 2007146996A2 · 2007 [cited by applicant]
WO 2007135368A3 · 2008 [cited by applicant]
U.S. Appl. No. 16/882,461, Final Office Action mailed On Dec. 29, 2021, 16 pages. [cited by applicant]
International Application No. PCT/US2009/032303, International Preliminary Report on Patentability mailed On Aug. 12, 2010, 8 pages. [cited by applicant]
Abi Prism® BigDye™ Terminator Cycle Sequencing Kits, Applied Biosystem, Product Bulletin, Automated DNA Sequencing, 2000, 4 pages. [cited by applicant]
Illumina Exhibit 25, US 2006/0063264 (“Turner I”), 22 pages. [cited by applicant]
Illumina Exhibit B-25, US 2006/0063264 (“Turner I”), 16 pages. [cited by applicant]
Illumina Supplemental Exhibit 23, U.S. Pat. No. 7,226,734 (“Chee III”), 70 pages. [cited by applicant]
Illumina Supplemental Exhibit B-23, U.S. Pat. No. 7,226,734 (“Chee III”), 52 pages. [cited by applicant]
Base Pair, Wikipedia, Available Online at: https://en.wikipedia.org/wiki/Base_pair#:˜:text=A%20base%20pair%20(bp)%20is,of%20both%20DNA%20and%20RNA., Jun. 7, 2021, pp. 1-7. [cited by applicant]
[cited by applicant]
Defendant Illumina Inc.'s Initial Invalidity Contentions, Complete Genomics Inc. V Ilumina Inc. C.A. No. 19-970-MN, Apr. 29, 2020, 33 pages. [cited by applicant]
DNA Sequencing with Solexa Technology, Illumina's Systems & Software Technology Spotlight, 2007, 4 pages. [cited by applicant]
Fluorescent Dyes for Bioanalytical and Hightech Applications, Dyomics Colours for Life, 4th Ed, 2005, 74 pages. [cited by applicant]
Fluorophore, Wikipedia, Available Online at: https://en.wikipedia.org/wiki/Fluorophore, May 28, 2021, 11 pages. [cited by applicant]
Genome Analyzer Data Analysis Software, Illumina, 2008, 2 Pages. [cited by applicant]
IPR2020-00079, Illumina Incorporated v. Complete Genomics Incorporated, Paper 2, Oct. 21, 2019, 100 pages. [cited by applicant]
IPR2020-00079, Illumina, Incorporated, Complete Genomics, Incorporated., Decision Denying Institution of Inter Partes Review, Apr. 22, 2020, 46 pages. [cited by applicant]
Joint Claim Construction Brief Re: U.S. Pat. Nos. 9,222,132 and 10,662,473, [cited by applicant]
Illumina Invalidity Contentions Exhibit B-10, US 2005/0181394 (Steemers), Jul. 31, 2020, 32 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit 01, WO 2006/064199 (Fedurco), Apr. 29, 2020, 6 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit 02, U.S. Pat. No. 6,833,246 (“Balasubramanian”), Apr. 29, 2020, 6 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit 03, WO 2004/018493 (Milton I), Apr. 29, 2020, 6 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit 04, WO 2004/018497 (Milton II), Apr. 29, 2020, 6 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit 05, U.S. 2005/0191698 (Chee I), Apr. 29, 2020, 6 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit 06, WO 2007/123744 (Banerjee), Apr. 29, 2020, 6 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit 07, Solexa Genome Analyzer, Apr. 29, 2020, 6 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit 08, U.S. Pat. No. 5,436,130 (Mathies I), Apr. 29, 2020, 6 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit 09, U.S. Pat. No. 6,403,301 (Chan), Apr. 29, 2020, 6 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit 10, US 2005/0181394 (Steemers), Apr. 29, 2020, 6 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit 11, U.S. Pat. No. 7,033,754 (Chee II), Apr. 29, 2020, 6 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit 12, US 2005/0100893 (Gunderson), Apr. 29, 2020, 6 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit 13, US 2004/007 6998 (Lexow), Apr. 29, 2020, 6 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit 14, Analytical Chemistry Excerpt (Huang I), Apr. 29, 2020, 6 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit 15, Automated DNA Sequencing and Analysis (Huang II), Apr. 29, 2020, 6 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit 16, DNA Sequencing by Capillary Electrophoresis (Ruiz-Martinez), Apr. 29, 2020, 6 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit 17, Frontiers in DNA Sequencing (“Horn-Saban ”), Apr. 29, 2020, 6 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit 18, Laser-Based Detection System (Li I), Apr. 29, 2020, 6 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit 19, PerM: efficient mapping of short sequencing reads (Chen, Y), Apr. 29, 2020, 6 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit 20, Simple two-color array-based approach (Fortina), Apr. 29, 2020, 6 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit 21, Simple Two-Color Base-Calling Schemes (“Li II”), Apr. 29, 2020, 6 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit 22, U.S 201210141986AI (Kauhn), Jul. 31, 2020, 27 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit 23, U.S. Pat. No. 7,226,734 (Chee III), Jul. 31, 2020, 25 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit 24, U.S. Pat. No. 6,218,124 (Lee III), Sep. 17, 2020, 36 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit B-1, WO 2006/064199 (Fedurco), Jul. 31, 2020, 27 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit B-11, U.S. Pat. No. 7,033,754 (Chee II), Jul. 31, 2020, 62 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit B-12, US 2005/0100893 (Gunderson), Jul. 31, 2020, 69 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit B-13, US 2004/0076998 (Lexow), Jul. 31, 2020, 41 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit B-14, Analytical Chemistry Excerpt (Huang I), Jul. 31, 2020, 26 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit B-15, Automated DNA Sequencing and Analysis (Huang II), Jul. 31, 2020, 34 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit B-16, DNA Sequencing by Capillary Electrophoresis (Ruiz-Martinez), Jul. 31, 2020, 18 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit B-17, Frontiers in DNA Sequencing (Horn-Saban), Jul. 31, 2020, 70 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit B-18, Laser-Based Detection System (Li I), Jul. 31, 2020, 31 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit B-19, PerM: efficient mapping of short sequencing reads (Chen, Y), Jul. 31, 2020, 13 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit B-2, U.S. Pat. No. 6,833,246 (Balasubramanian), Jul. 31, 2020, 25 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit B-20, Intentionally Omitted, 1 page. [cited by applicant]
Illumina Invalidity Contentions Exhibit B-21, Simple Two-Color Base-Calling Schemes, (Li II), Jul. 31, 2020, 16 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit B-22, US 2012/0141986A1, (Kuhn), Jul. 31, 2020, 34 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit B-23, U.S. Pat. No. 7,226,734, (Chee III), Jul. 31, 2020, 28 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit B-3, WO 2004/018493 (Milton I), Jul. 31, 2020, 39 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit B-4, WO 2004/018497 (Milton II), Jul. 31, 2020, 57 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit B-5, U.S. 2005/0191698 (Chee I), Jul. 31, 2020, 58 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit B-6, WO 2007/123744 (Banerjee), Jul. 31, 2020, 21 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit B-7, Solexa Genome Analyzer, Jul. 31, 2020, 7 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit B-8, U.S. Pat. No. 5,436,130 (“Mathies I ”), Jul. 31, 2020, 47 pages. [cited by applicant]
Illumina Invalidity Contentions Exhibit B-9, U.S. Pat. No. 6,403,311 (Chan), Jul. 31, 2020, 84 pages. [cited by applicant]
Illumina Inc.'s Amended Initial Invalidity Contentions, [cited by applicant]
Illumina Inc.'sSecond Amended Initial Invalidity Contentions, [cited by applicant]
Illumina Inc.'sThird Amended Initial Invalidity Contentions, [cited by applicant]
Patent Owner's Preliminary Response, Case IPR2020-00079, U.S. Pat. No. 9,222,132, Jan. 29, 2020, 1 page. [cited by applicant]
Table of Fluorochromes, Available Online At: http://biotech.iastate.edu/facilities/flow/Fiuorochromes.pdf, Jun. 7, 2018, pp. 1-6. [cited by applicant]
Two Dye SBS Technical Review, Illumina, Apr. 12, 2011, 52 pages. [cited by applicant]
U.S. Appl. No. 60/690,771, Methods and Applications for Random DNA Array Preparation filed Jun. 15, 2005, 35 pages. [cited by applicant]
U.S. Appl. No. 60/725,116, Ultra-High Capacity Self-Assembled Detector Nano- Array (SADNA) Chips filed Oct. 7, 2005, 45 pages. [cited by applicant]
U.S. Appl. No. 60/776,415, Efficent Genome Analysis by Combinatorial Probe Ligation on DNA Arrays filed Feb. 24, 2006, 63 pages. [cited by applicant]
Aksyonov et al., Multiplexed DNA Sequencing-by-Synthesis, Analytical Biochemistry, vol. 348, No. 1, Jan. 1, 2006, pp. 127-138. [cited by applicant]
Alberts et al., Molecular Biology of the Cell, Third Edition, 1994, 34 pages. [cited by applicant]
Bay et al., Accuracy of Two-color Peak-height-encoded DNA Sequencing by Capillary Gel Electrophoresis and Laser-induced Fluorescence, Advances in DNA Sequencing Technology Proceedings of SPIE, vol. 1891, Jun. 24, 1993, … [cited by applicant]
Bentley, Whole-Genome Re-Sequencing, Current Opinion in Genetics & Development, vol. 16, No. 6, Dec. 2006, pp. 545-552. [cited by applicant]
Blanco et al., Highly Efficient DNA Synthesis by the Phage Phi 29 DNA Polymerase, The Journal Biological Chemistry, vol. 264, No. 15, May 25, 1989, pp. 8935-8940. [cited by applicant]
Braslavsky et al., Sequence Information Can be Obtained from Single DNA Molecules, Proceedings of National Academy of Science USA, vol. 100, No. 7, Apr. 1, 2003, pp. 3960-3964. [cited by applicant]
Brenner et al., Gene Expression Analysis by Massively Parallel Signature Sequencing (MPSS) on Microbead Arrays, Nature Biotechnology, vol. 18, No. 6, Jun. 2000, pp. 630-634. [cited by applicant]
Callow et al., Selective DNA Amplification from Complex Genomes Using Universal Double-Sided Adapters, Nucleic Acids Research, vol. 32, No. 2, Jan. 28, 2004, pp. 1-6. [cited by applicant]
Canard et al., DNA Polymerase Fluorescent Substrates With Reversible 3′-Tags, Gene, vol. 148, No. 1, Oct. 11, 1994, pp. 1-6. [cited by applicant]
Chen et al., A Homogeneous, Ligase-Mediated DNA Diagnostic Test, Genome Research, vol. 8, No. 5, May 1998, pp. 549-556. [cited by applicant]
Chen et al., PerM: Efficient Mapping of Short Sequencing Reads with Periodic Full Sensitive Spaced Seeds, Bioinformatics, vol. 25, No. 19, Sep. 2009, 10 pages. [cited by applicant]
Chen et al., Single-color Laser-Induced Fluorescence Detection and Capillary Gel Electrophoresis for DNA Sequencing, SPIE, vol. 1435, Jul. 1, 1991, 7 pages. [cited by applicant]
Chen et al., Two-label Peak-height Encoded DNA Sequencing by Capillary Gel Electrophoresis: Three Examples, Nucleic Acids Research, vol. 20, No. 18, Sep. 25, 1992, pp. 4873-4880. [cited by applicant]
Collins et al., Directional Cloning of DNA Fragments at a Large Distance from an Initial Probe: A Circularization Method, Proceedings of the National Academy of Sciences USA, vol. 81, No. 21, Nov. 1984, pp. 6812-6816. [cited by applicant]
Cowie et al., Identification of APC Gene Mutations in Colorectal Cancer Using Universal Microarray-Based Combinatorial Sequencing-By-Hybridization, Human Mutation, vol. 24, No. 3, Sep. 2004, pp. 261-271. [cited by applicant]
Dahl et al., Multiplex Amplification Enabled by Selective Circularization of Large Sets of Genomic DNA Fragments, Nucleic Acids Research, vol. 33, No. 8, Apr. 28, 2005, pp. 1-7. [cited by applicant]
Dorre et al., Techniques for Single Molecule Sequencing, Bioimaging, vol. 5, 1997, pp. 139-152. [cited by applicant]
Dovichi et al., How Capillary Electrophoresis Sequenced the Human Genome, Angewandte Chemie International Edition: vol. 39, No. 24, Dec. 15, 2000, pp. 4463-4468. [cited by applicant]
Drmanac et al., Sequencing by Hybridization (SBH): Advantages Achievements and Opportunities, Advances in Biochemical Engineering Biotechnology, vol. 77, Jun. 2001, pp. 75-101. [cited by applicant]
European Application No. EP12766838.2, Notice of Opposition mailed on Apr. 12, 2018, 34 pages. [cited by applicant]
European Application No. EP12766838.2, Response by Patent Owner in Opposition mailed on Sep. 5, 2018, 145 pages. [cited by applicant]
Epstein et al., Combinatorial Decoding: An Approach for Universal DNA Array Fabrication, Journal of the American Chemical Society, vol. 125, No. 45, Jun. 7, 2003, pp. 13753-13759. [cited by applicant]
Feng, Re: Evolve SDFs, Sep. 29, 2007, 3 pages. [cited by applicant]
Foldes-Papp et al., Fluorescent High-density Labeling of DNA: Error-free Substitution for a Normal Nucleotide, Journal of Biotechnology, vol. 86, Aug. 27, 1999, pp. 237-253. [cited by applicant]
Foldes-Papp et al., Fluorescently Labeled Model DNA Sequences for Exonucleolytic Sequencing, Journal of Biotechnology, vol. 86, No. 3, Apr. 13, 2001, pp. 203-224. [cited by applicant]
Fortina et al., Simple Two-color Array-based Approach for Mutation Detection, European Journal of Human Genetics, vol. 8, Oct. 31, 2000, pp. 884-894. [cited by applicant]
Fuller et al., Chapter 46 Basic DNA and RNA Protocols Methods in Molecular Biology, vol. 58, 1996, pp. 373-387. [cited by applicant]
Fung et al., High-speed DNA Sequencing by Using Mixed Poly (Ethylene Oxide) Solutions in Uncoated Capillary Columns Analytical Chemistry, vol. 67, No. 13, Jul. 1, 1995, pp. 1913-1919. [cited by applicant]
Griffin et al., Chapter 14 Methods in Molecular Biology, DNA Sequencing Protocols, vol. 23, 1993, 9 pages. [cited by applicant]
Haugland, Handbook of Fluorescent Probes and Research Products, Molecular Probes 9th Edition, 2002, 22 pages. [cited by applicant]
Hom-Saban et al., Frontiers in DNA Sequencing: the (R) Evolution of Sequencing Technologies, Encyclopedia of Analytical Chemistry: Applications Theory and Instrumentation, Dec. 2011, pp. 1-30. [cited by applicant]
Huang et al., Application of Capillary Array Electrophoresis to DNA Sequencing, Automated DNA sequencing and Analysis, Chapter 3, 1994, pp. 17-28. [cited by applicant]
Huang et al., DNA Sequencing Using Capillary Array Electrophoresis, Analytical Chemistry, vol. 64, No. 18, Sep. 15, 1992, pp. 2149-2154. [cited by applicant]
Jarvie, Next Generation Sequencing Technologies, Science Direct, Drug Discovery Today: Technologies, vol. 2, No. 3, 2005, pp. 255-260. [cited by applicant]
Ju et al., Four-color DNA Sequencing by Synthesis Using Cleavable Fluorescent Nucleotide Reversible Terminators, Proceedings of the National Academy Science USA, vol. 103, No. 52, Dec. 26, 2006, pp. 19635-19640. [cited by applicant]
Kain, 2 Dye Sequencing, Mar. 29, 2007, 1 page. [cited by applicant]
Kambara et al., Real Time Automated Simultaneous Doublestranded DNA Sequencing Using Two-Color Fluorophore Labeling, Biotechnology, vol. 9, Jul. 1991, pp. 648-651. [cited by applicant]
Kartalov et al., Microfluidic Device Reads Up to Four Consecutive Base Pairs in DNA Sequencing-by-Synthesis, Nucleic Acids Research, vol. 32, No. 9, May 20, 2004, pp. 2873-2879. [cited by applicant]
Kheterpal et al., New Methods for DNA Analysis Using Capillary Electrophoresis and Laser-Induced Fluorescence Detection, University of California Berkeley, 1998, 212 pages. [cited by applicant]
Ladner et al., Multiplex Detection of Hotspot Mutations by Rolling Circle-Enabled Universal Microarrays, Laboratory Investigation, vol. 81, No. 8, Aug. 1, 2001, pp. 1079-1086. [cited by applicant]
Lee et al., New Energy Transfer Dyes for DNA Sequencing, Nucleic Acids Research, vol. 25, No. 14, Jul. 15, 1997, pp. 2816-2822. [cited by applicant]
Li et al., Beaming Up for Detection and Quantification of Rare Sequence Variants, Nature Methods, vol. 3, No. 2, Feb. 2006, pp. 95-97. [cited by applicant]
Li et al., Laser-based Detection System for High-throughput DNA Sequencing with Multiplexed Capillary Electrophoresis, Lowa State University, 1995, 303 pages. [cited by applicant]
Li et al., Simple Two-Color Base-Calling Schemes for DNA Sequencing Based on Standard Four-Label Sanger Chemistry, Applied Spectroscopy, vol. 49, No. 10, Oct. 1, 1995, pp. 1528-1533. [cited by applicant]
Lu et al., High-Speed and High-Accuracy DNA Sequencing by Capillary Gel Electrophoresis in a Simple, Low Cost Instrument. Two-Color Peak-Height Encoded Sequencing at 40 Degrees C, Journal of Chromatography A, vol. 680, … [cited by applicant]
Margulies et al., Genome Sequencing in Microfabricated High-Density Picolitre Reactors, Nature, vol. 437, No. 7057, Sep. 15, 2005, pp. 376-380. [cited by applicant]
Metzker, Emerging Technologies in DNA Sequencing, Genome Research, vol. 15, Issue 12, Dec. 2005, pp. 1767-1776. [cited by applicant]
Metzker, Sequencing Technologies—The Next Generation, Nature Reviews Genetics, vol. 11, Jan. 2010, pp. 31-46. [cited by applicant]
Metzker et al., Termination of DNA Synthesis by Novel3′-Modifieddeoxyribonucleoside 5′-Triphosphates, Nucleic Acids Research, vol. 22, No. 20, Oct. 11, 1994, pp. 4259-4267. [cited by applicant]
Nunnally et al., Characterization of Visible Dyes for Four-Decay Fluorescence Detection in DNA Sequencing, Analytical Chemistry, vol. 69, No. 13, Jul. 1, 1997, pp. 2392-2397. [cited by applicant]
International Application No. PCT/US2009/032303, International Search Report and Written Opinion mailed on Jul. 29, 2009, 10 pages. [cited by applicant]
Prober et al., A System for Rapid DNA Sequencing with Fluorescent Chain-Terminating Dideoxynucleotides, Science, vol. 238, Oct. 16, 1987, pp. 336-341. [cited by applicant]
Quesada et al., High-sensitivity DNA Detection with a Laser-Excited Confocal Fluorescence Gel Scanner, Biotechniques, vol. 10, No. 5, Apr. 30, 1991, pp. 616-625. [cited by applicant]
Ronaghi, Pyrosequencing sheds light on DNA sequencing., Genome Research, vol. 11, No. 1, Jan. 2001, pp. 3-11. [cited by applicant]
Ronaghi et al., Real-Time DNA Sequencing Using Detection of Pyrophosphate Release, Analytical Biochemistry, vol. 242, Nov. 1996, pp. 84-89. [cited by applicant]
Rosenthal, DNA Sequencing by Chemical Degradation Using One, Two and Four Different Fluorophores, DNA Sequencing Protocols, Methods in Molecular Biology, vol. 23, 1993, pp. 261-280. [cited by applicant]
Ruiz-Martinez et al., DNA Sequencing by Capillary Electrophoresis with Replaceable Linear Polyacrylamide and Laser-induced Fluorescence Detection, Analytical Chemistry, vol. 65, No. 20, Oct. 15, 1993, pp. 2851-2858. [cited by applicant]
Ruparel et al., Design and Synthesis of A 3′-O-Allyl Photocleavable Fluorescent Nucleotide as a Reversible Terminator for DNA Sequencing by Synthesis, Proceedings of the National Academy of Sciences, vol. 102, No. 17, A… [cited by applicant]
Sanger et al., DNA Sequencing with Chain-Terminating Inhibitors, Proceedings of the National Academy of Sciences, vol. 74, No. 12, Dec. 1977, pp. 5463-5467. [cited by applicant]
Sauer et al., Detection and Identification of Single Dye Labeled Mononucleotide Molecules Released from an Optical Fiber in a Microcapillary: First Steps Towards a New Single Molecule DNA Sequencing Technique, Physical … [cited by applicant]
Shendure et al., Accurate Multiplex Polony Sequencing of an Evolved Bacterial Genome, Science, vol. 309, No. 5741, Sep. 9, 2005, pp. 1728-1732. [cited by applicant]
Shendure et al., Advanced Sequencing Technologies: Methods and Goals, Nature Reviews Genetics, vol. 5, No. 5, May 2004, pp. 335-344. [cited by applicant]
Smirnov et al., Method for Manufacturing Whole-Genome Microarrays by Rolling Circle Amplification, Genes, Chromosomes & Cancer, vol. 40, No. 1, May 2004, pp. 72-77. [cited by applicant]
Smith et al., Fluorescence detection in automated DNA sequence analysis, Nature, vol. 321, 1986, pp. 674-679. [cited by applicant]
Smith et al., Using Quality Scores and Longer Reads Improves Accuracy of Solexa Read Mapping, BMC Bioinformatics, vol. 9, No. 128, Feb. 28, 2008, pp. 1-8. [cited by applicant]
Staden, Computer Methods to Locate Signals in Nucleic Acid Sequences, Nucleic Acids Research, vol. 12, No. 1, Jan. 11, 1984, pp. 505-519. [cited by applicant]
Starke, Capillary Gel Electrophoresis for DNA Sequencing, University of Alberta, 1994, 202 pages. [cited by applicant]
Starke et al., Internal Fluorescence Labeling with Fluorescent Deoxynucleotides in Two-label Peak-height Encoded DNA Sequencing by Capillary Electrophoresis, Nucleic Acids Research, vol. 22, No. 19, Sep. 25, 1994, pp. 3… [cited by applicant]
Tabor et al., DNA Sequence Analysis with a Modified Bacteriophage T7 DNA Polymerase, The Journal of Biological Chemistry, vol. 265, No. 14, May 15, 1990, pp. 8322-8328. [cited by applicant]
Tringe et al., Metagenomics: DNA Sequencing of Environmental Samples, Nature Reviews Genetics, vol. 6, No. 11, Nov. 2005, pp. 805-814. [cited by applicant]
Vingron et al., Sequence Alignment and Penalty Choice. Review of Concepts, Case Studies and Implications, Journal of Molecular Biology, vol. 235, No. 1, Jan. 7, 1994, pp. 1-12. [cited by applicant]
Voss et al., Efficient Low Redundancy Large-Scale DNA Sequencing at EMBL, Journal of Biotechnology, vol. 41, No. 2, Jul. 31, 1995, pp. 121-129. [cited by applicant]
Watson et al., Genetical Implications of the Structure of Deoxyribonucleic Acid, Nature, vol. 171, May 30, 1953, pp. 964-967. [cited by applicant]
Whiteford et al., An Analysis of the Feasibility of Short Read Sequencing, Nucleic Acids Research, vol. 33, No. 19, Nov. 7, 2005, pp. 1-6. [cited by applicant]
Wiemann et al., Doublex Fluorescent DNA Sequencing: Two Independent Sequences Obtained Simultaneously in One Reaction with Internal Labeling and Unlabeled Primers, Analytical Biochemistry, vol. 234, No. 2, Feb. 1996, pp… [cited by applicant]